TyG指数与2型糖尿病合并慢性心力衰竭的相关性
摘要
方法该研究为一项临床回顾性研究选取2022年8月-2024年12月于安徽医科大学第一附属医院住院治疗确
诊为2型糖尿病的患者209例将其分为2型糖尿病组n=108与2型糖尿病合并慢性心力衰竭组n=101收集
各组患者的基本资料、血液学指标及心脏彩超指标等比较两组患者上述资料及TyG指数的差异采用Logistic回
归分析筛选出T2DM合并慢性心力衰竭的危险因素结果一般资料比较显示两组性别及年龄比较无明显差异
P0.05具有可比性T2DM合并慢性心力衰竭组TyG指数、糖化血红蛋白HbA1c、左心房内径LA、左
心室舒张末期内径LVD均高于T2DM组总胆固醇TC、高密度脂蛋白HDL-C、非高密度脂蛋白nonHDL-C、左心室射血分数EF、估算的肾小球滤过率eGFR低于T2DM组差异有统计学意义P0.05
Logistic回归分析显示Ty-G指数、HbA1c为T2DM合并慢性心力衰竭的危险因素P<0.05结论Ty-G指数、
HbA1c为T2DM合并慢性心力衰竭的危险因素。
关键词
全文:
PDF参考
[1]CABANILLAS-LAZO M, QUISPE-VICUÑA C,
PASCUAL-GUEVARA M, et al. Diagnostic accuracy of
triglyceride to glucose index and triglyceride/high-density
lipoprotein index for insulin resistance among children and
adolescents: A systematic review[J]. PloS One, 2025, 20(6):
e0326179. DOI:10.1371/journal.pone.0326179.
[2]DA SILVA A, CALDAS A P S, ROCHA D M U P,
et al. Triglyceride-glucose index predicts independently type
2 diabetes mellitus risk: A systematic review and meta-analysis
of cohort studies[J]. Primary Care Diabetes, 2020, 14(6): 584-
593. DOI:10.1016/j.pcd.2020.09.001.
[3]NABIPOORASHRAFI S A, SEYEDI S A,
RABIZADEH S, et al. The accuracy of triglyceride-glucose
(TyG) index for the screening of metabolic syndrome in
adults: A systematic review and meta-analysis[J]. Nutrition,
metabolism, and cardiovascular diseases: NMCD, 2022,
32(12): 2677-2688. DOI:10.1016/j.numecd.2022.07.024.
[4]CEFALO C M A, RICCIO A, FIORENTINO T
V, et al. The triglyceride glucose (TyG) index is associated
with decreased myocardial mechano-energetic efficiency in
individuals with different glucose tolerance status[J]. European
Journal of Clinical Investigation, 2025, 55(6): e70013.
DOI:10.1111/eci.70013.
49
现代医学前沿 | 第4卷/第4期
Advances in Modern Medical
[5]LI X, LI G, CHENG T, et al. Association between
triglyceride-glucose index and risk of incident diabetes: a
secondary analysis based on a Chinese cohort study : TyG
index and incident diabetes[J]. Lipids in Health and Disease,
2020, 19(1): 236. DOI:10.1186/s12944-020-01403-7.
[6]CHAMROONKIADTIKUN P, ANANCHAISARP
T, WANICHANON W. The triglyceride-glucose index,
a predictor of type 2 diabetes development: A retrospective
cohort study[J]. Primary Care Diabetes, 2020, 14(2): 161-
167. DOI:10.1016/j.pcd.2019.08.004.
[7]NI W, JIANG R, XU D, et al. Association between
insulin resistance indices and outcomes in patients with heart
failure with preserved ejection fraction[J]. Cardiovascular
Diabetology, 2025, 24(1): 32. DOI:10.1186/s12933-025-
02595-x.
[ 8 ] K H A L A J I A , B E H N O U S H A H ,
KHANMOHAMMADI S, et al. Triglyceride-glucose index
and heart failure: a systematic review and meta-analysis[J].
Cardiovascular Diabetology, 2023, 22(1): 244. DOI:10.1186/
s12933-023-01973-7.
[9]HE H M, XIE Y Y, CHEN Q, et al. The synergistic
effect of the triglyceride-glucose index and a body shape
index on cardiovascular mortality: the construction of a novel
cardiovascular risk marker[J]. Cardiovascular Diabetology,
2025, 24(1): 69. DOI:10.1186/s12933-025-02604-z.
[10]JIA Y, ZHANG Y, BAI S, et al. Triglyceride
glucose index is a risk factor for heart failure: A prospective
cohort study[J]. ESC heart failure, 2024, 11(6): 3833-3841.
DOI:10.1002/ehf2.14963.
[11]DILLINGER J G, PATIN C, BONNIN P, et al.
Elevated Brain Natriuretic Peptide and High Brachial Pulse
Pressure in Patients With Diabetes[J]. American Journal of
Hypertension, 2022, 35(5): 414-422. DOI:10.1093/ajh/
hpab179.
[12]CAI Y, YANG M, MA S, et al. A metaanalysis of the prognostic value of the TyG index in heart
failure[J]. Frontiers in Endocrinology, 2025, 16: 1463647.
DOI:10.3389/fendo.2025.1463647.
[13]YU Z, LIU W, LI B, et al. Triglyceride-glucose
index and the prognosis of patients with heart failure: A
meta-analysis[J]. Biomolecules & Biomedicine, 2025, 25(2):
278-290. DOI:10.17305/bb.2024.10559.
[14]WANG Z, LI W, LI J, et al. The Nonlinear
Correlation Between a Novel Metabolic Score for Insulin
Resistance and Subclinical Myocardial Injury in the General
Population[J]. Frontiers in Endocrinology, 2022, 13: 889379.
DOI:10.3389/fendo.2022.889379.
[15]PARK J J. Epidemiology, Pathophysiology,
Diagnosis and Treatment of Heart Failure in Diabetes[J].
Diabetes & Metabolism Journal, 2021, 45(5): 796.
DOI:10.4093/dmj.2021.0239.
[16]PANDEY A, KHAN M S, PATEL K V, et al.
Predicting and preventing heart failure in type 2 diabetes[J].
The Lancet. Diabetes & Endocrinology, 2023, 11(8): 607-
624. DOI:10.1016/S2213-8587(23)00128-6.
[17]LU M, GUO J, YANG P, et al. Insulin resistance
markers HOMA-IR, TyG and TyG-BMI index in relation
to heart failure risk: NHANES 2011-2016[J]. PloS One,
2025, 20(9): e0331740. DOI:10.1371/journal.pone.0331740.
[18]RATHORE V, GAIKWAD K, MAHAT R K.
Assessment of TyG Index and Modified TyG Indices in Type
2 Diabetes Mellitus: Evaluating Their Potential as Predictors
of Glycemic Control[J]. Cureus, 2025, 17(3): e80785.
DOI:10.7759/cureus.80785.
[19]WU L, HUANG Z. Elevated triglyceride glucose
index is associated with advanced cardiovascular kidney
metabolic syndrome[J]. Scientific Reports, 2024, 14(1):
31352. DOI:10.1038/s41598-024-82881-y.
[20]ZHANG P, MO D, ZENG W, et al. Association
between triglyceride-glucose related indices and all-cause
and cardiovascular mortality among the population with
cardiovascular-kidney-metabolic syndrome stage 0-3: a
cohort study[J]. Cardiovascular Diabetology, 2025, 24(1): 92.
DOI:10.1186/s12933-025-02642-7.
[21]ZHANG H, TU Z, LIU S, et al. Association
of different insulin resistance surrogates with all-cause
and cardiovascular mortality among the population with
cardiometabolic multimorbidity[J]. Cardiovascular Diabetology,
2025, 24(1): 33. DOI:10.1186/s12933-025-02576-0.
[22]LEE J H, JEON S, LEE H S, et al. Trajectories
of triglyceride-glucose index changes and their association
with all-cause and cardiovascular mortality: a competing risk
analysis[J]. Cardiovascular Diabetology, 2024, 23(1): 364.
DOI:10.1186/s12933-024-02457-y.
Refbacks
- 当前没有refback。
